ACE and heart failure: This finding is consistent with a study conducted in Jimma, Ethiopia among hospitalized heart failure patients, where beta blockers (35%), angiotensin-converting enzyme inhibitors (25%), antithrombotics (20%), and statins (16%) were frequently implicated in DTPs [43].